Jazz Pharmaceuticals (JAZZ) Change in Acquisitions & Divestments (2012 - 2026)

Jazz Pharmaceuticals' Change in Acquisitions & Divestments history runs 12 years deep, the most recent figure standing at $520.0 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 67.74% year-over-year to $520.0 million; the TTM figure through Mar 2026 stood at $1.6 billion (up 51.69% YoY), while the FY2025 annual figure was $1.4 billion, up 60.95% from the prior year.
• Change in Acquisitions & Divestments was $520.0 million for Q1 2026 at Jazz Pharmaceuticals, up from $180.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $520.0 million in Q1 2026 to a low of $20.0 million in Q3 2023.
• Historically, Change in Acquisitions & Divestments has averaged $254.6 million across 5 years, with a median of $270.0 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Change in Acquisitions & Divestments jumped 1675.0% in 2024, then slumped 37.93% in 2025.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $60.0 million in 2022, then jumped by 316.67% to $250.0 million in 2023, then advanced by 16.0% to $290.0 million in 2024, then plunged by 37.93% to $180.0 million in 2025, then soared by 188.89% to $520.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $520.0 million (Q1 2026), $180.0 million (Q4 2025), and $400.0 million (Q3 2025), per Business Quant data.